Table 2 Summary of radiologic and pathologic characteristics of the two cohorts of patients included in this study. *4 patients had PI-RADS 1 scores, and 1 patient had PI-RADS 2 scores. **27 patients had PI-RADS 1 scores, and 4 patients had PI-RADS 2 scores. †Part of a prospective research study without clinical evaluation by a radiologist.

From: Utility of quantitative measurement of T2 using restriction spectrum imaging for detection of clinically significant prostate cancer

Cohort 1 (n = 46)

Available pathology

Systematic biopsy only

6

Targeted Biopsy Only

0

Systematic and targeted biopsy

20

Prostatectomy

15

No biopsy or prostatectomy*

5

PI-RADS

1

9

2

2

3

10

4

10

5

15

Not available

0

Gleason grade group

Benign

17

1

2

2

9

3

8

4

1

5

4

Cohort 2 (n = 195)

Available pathology

Systematic biopsy only

44

Targeted Biopsy Only

5

Systematic and targeted biopsy

60

Prostatectomy

28

No biopsy or prostatectomy**

31

PI-RADS

1

66

2

10

3

18

4

36

5

27

Not available†

38

Gleason grade group

Benign

38

1

30

2

40

3

32

4

7

5

17